Incidental Detection of Urothelial Carcinoma on 18F-Fluciclovine PET/CT

Bladder Cancer

Clin Nucl Med. 2020 Nov 3. doi: 10.1097/RLU.0000000000003342. Online ahead of print.


F-Fluciclovine PET/CT has become a common diagnostic imaging study used in the evaluation of biochemical recurrence in prostate cancer since its approval in 2016. We present a case report of an 82-year-old man with history of both prostate and bladder cancer who presented for a fluciclovine study due to rising PSA levels. There was incidental detection of focal penile activity, and a subsequent urethral biopsy performed showed urothelial carcinoma, which was also seen on a subsequent MRI study.